ENVI - Exchange of views with Dr Andrea AMMON, Director of the European Centre for Disease Prevention and Control (ECDC)

ENVI Exchange of views with Sharon McGUINNESS, Executive Director of the European Chemicals Agency (ECHA)

EP Plenary session - Voting session including 2024 budget procedure and signing ceremony

Press briefing RENEW Europe

EP Plenary session - Strengthening the CO2 emission performance targets for new heavy-duty vehicles

Upcoming Belgian Presidency of the Council - Ambassador Pierre CARTUYVELS meets with Pascal CANFIN, ENVI committee Chair

Statement by Pascal CANFIN, Chair of ENVI Committee on Vaccine deliveries and contracts transparency

ENVI -  Committee on the Environment, Public Health and Food Safety - State of play with the assessment and authorization of vaccines against COVID-19 - Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency (EMA)

ENVI - Committee on Environment, Public Health and Food Safety - Water directive

ENVI - Committee on the Environment, Public Health and Food SafetyBuilding of a European Health Union - Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety, on the building of a European Health Union: the Preparedness and Resilience Package and the Pharmaceutical Strategy

Public Hearing - How to secure access to COVID-19 vaccines for EU citizens

ENVI Meeting - EU Strategy on adaptation to climate change

ENVI meeting, Committee on the Environment, Public Health and Food Safety - Exchange of views with the Commission on the EU vaccines strategy, including the state of play on the Vaccines Advance Purchase Agreement

ENVI Committee on the Environment, Public Health and Food Safety - Exchange of views with Director of the European Centre for Disease Prevention and Control (ECDC)

ENVI Committee meeting - Exchange of views with Dr Tedros ADHANOM GHEBREYESUS, Director General WHO

ENVI Committee meeting - Exchange of views with Commissioner Adina VALEAN

Due to strict sanitary measures to avoid COVID-19 spreading, Parliament has put in place temporary measures to allow members to fulfil their democratic rights and legislative duties. Parliament has put in place measures for Members to participate to committees from a distance.

ENVI Committee - Exchange of views with Frans TIMMERMANS,  Executive Vice-President of the European Commission in charge of the European Green Deal

ENVI committee meeting. Update by the Commission on the COVID-19 (Coronavirus) situation

ENVI committee meeting - Outbreak of Coronavirus pneumonia - Exchange of views with Andrea AMMON, Executive Director of the European Centre for Disease Prevention and Control.

ENVI committee meeting - Exchange of views with Thierry BRETON, Commissioner for Internal Market

Conference : ' Sustainable Oceans for the Future - Green Blue Deal '

ENVI Committee meeting - Public hearing ' Reducing Greenhouse gas emissions from EU-related maritime transport : what's next after the EU MRV '

ENVI Committee meeting - Exchange of views with Marija VUCKOVIC, Croatian Minister of Agriculture

ENVI Committee meeting - Exchange of views with Tomislav CORIC, Croatian Minister of Environment and Energy

During the plenary session (7-10 June 2021) in the European Parliament in Strasbourg, MEPs debate the EU Biodiversity Strategy for 2030 - Bringing nature back into our lives. The EU’s biodiversity strategy for 2030 is a comprehensive, ambitious and long-term plan to protect nature and reverse the degradation of ecosystems. The strategy aims to put Europe's biodiversity on a path to recovery by 2030, and contains specific actions and commitments. It is the proposal for the EU’s contribution to the international negotiations on the global post-2020 biodiversity framework.

EU Biodiversity Strategy for 2030 - Bringing nature back into our lives: MEPs debate (part 1/2)

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) have an exchange of views with the World Health Organization (WHO) on the European Union Health Union package and the WHO’s global response to the pandemic. Presentation by Jaouad MAHJOUR, Assistant Director-General, Emergency Preparedness and International Health Regulations at World Health Organization and statements by Sylvie BRIAND, Director of the Global Infectious Hazard Preparedness (GIH), WHO Emergency Preparedness (WPE) and by Nedret EMIROGLU, Director, Country Readiness Strengthening. The transcription of the speeches is the result of an automatic process. Check against delivery.

The European Union Health Union package and the WHO’s global response to the pandemic: opening, presentation and exchange of views with the World Health Organization (recorded)

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) have an exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety, in the European Parliament in Brussels. Opening remark by Pascal CANFIN (Renew,FR), ENVI Chair and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety, as part of the structured dialogue. The transcription of the speeches is the result of an automatic process. Check against delivery.

Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety, in ENVI Committee: Opening remark by Pascal CANFIN (Renew, FR), ENVI Chair and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

Jytte GUTELAND (S&D, SE), rapporteur and Pascal CANFIN (Renew, FR), ENVI Chair, give a press confenrece following the trilogue on Climate law, in the European Parliament in Brussels.

Press conference by Jytte GUTELAND (S&D, SE), rapporteur and Pascal CANFIN (Renew, FR), ENVI Chair following the trilogue on Climate law

Views of the trilogue meeting (20/04) and statements by Jytte GUTELAND (S&D, SE), rapporteur, and Pascal CANFIN (Renew, FR), ENVI Chair, following the agreement reached on the EU’s climate law. The new legislation increases the EU’s 2030 emissions reductions target from 40% to at least 55%, while boosting the contribution from removals that can bring the target to 57%.

Outcome of the trilogue on Climate law: views of the meeting, statement by Jytte GUTELAND (S&D, SE), rapporteur, and Pascal CANFIN (Renew, FR), ENVI Chair, and extracts of the press conference

Members of the Environment, Public Health and Food Safety (ENVI) Committee had an exchange of views on a new legislation for a faster authorisation procedure for COVID-19 vaccines that have already received EU authorisation, but which are being adapted to be effective against variants of the virus.

Quicker authorization procedure for adapted COVID-19 vaccines: exchange of views and statement by Cristian-Silviu BUŞOI (EPP, RO), Chair of the EP Committee on Industry, Research and Energy

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE. This transcription speech is the result of an automatic process. Check against delivery.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Questions & answers

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: questions & answers

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

The Environment, Public Health and Food Security Committee (ENVI) hold a debate on COVID-19 variants and how effective vaccines are against them with representatives from the European Medicine Agency (EMA), the European Centre for Disease Prevention and Control (ECDC) and the World Health Organisation (WHO). Following this meeting, Pascal CANFIN (RE, FR), ENVI Chair, gives a statement on a faster authorisation process for updated vaccines and on the role of vaccination certificates.

COVID-19 variants and the vaccines' efficacy: statement by Pascal CANFIN (Renew, FR), ENVI Chair

Members of the EP Committee on Environment, Public Health and Food Safety exchange their views on COVID-19 variants and the vaccines' efficacy. Opening statements by Pascal CANFIN (Renew, FR), ENVI Chair, Marco CAVALERI, Head of Biological health threats and vaccines strategy and Chair of the COVID-19 Emergency Task Force, EMA, Bruno CIANCO, Head of Surveillance section, ECDC and Katherine O’BRIEN, Department of Immunization, Vaccines and Biologicals Director, World Health Organization, (WHO)

Exchange of views on COVID-19 variants and the vaccines' efficacy: opening statements by Pascal CANFIN (Renew, FR), ENVI Chair, Marco CAVALERI (EMA), Bruno CIANCO (ECDC) and Katherine O’BRIEN (WHO)

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs participate in a joint debate on the European Semester: opening remark by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade. Opening statements by Markus FERBER (EPP, DE), Lina GÁLVEZ MUÑOZ (S&D, ES), rapporteurs, Margarida MARQUES (S&D, PT), (BUDG); Nils UŠAKOVS (S&D, LV) BUDG, Ana Paula ZACARIAS, Portuguese Presidency, President in office of the European Council, and Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade, and Nicolas SCHMIT, European Commissioner for Jobs and Social Rights, Pascal CANFIN (Renew, FR) (ENVI) and Victor NEGRESCU (S&D, RO) (CULT). This transcription speech is the result of an automatic process. Check against delivery.

European Semester: Opening statements

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on "a WTO-compatible EU carbon border adjustment mechanism" (Part 1).

A WTO-compatible EU carbon border adjustment mechanism: MEPs debate (part 1)

Members of the Public Health (ENVI) and Industry (ITRE) committees debate how to increase capacity and improve delivery of COVID-19 vaccines with pharmaceutical companies (AstraZeneca, Moderna, CureVac, Novavax, Johnson & Johnson, Pfizer Group and Sanofi Pasteur) and Commissioners Thierry Breton and Stella Kyriakides. Statements of MEPs : CANFIN Pascal (Renew, FR), BUŞOI Cristian-Silviu (EPP, RO), GUTELAND Jytte (S&D, SE), BALDASSARRE Simona (ID, IT). Statements of CEOs of pharmaceutical companies : SORIOT Pascal, CEO AstraZeneca, BANCEL Stéphane, CEO Moderna, HAAS Franz-Werner, CEO Curevac, ERCK Stan, CEO Novavax, HWANG Angela, CEO Pfizer, STOFFELS Paul, CEO Johnson & Johnson, TRIOMPHE Thomas, CEO Sanofi.

How to increase the capacity of COVID 19 vaccine production and improve delivery: extracts from the Joint ENVI-ITRE hearing

Statements by Pascal CANFIN (Renew, FR), ENVI chair, and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair, following the exchange of views with CEOs of the pharmaceutical industry on COVID 19 vaccine production and delivery.

COVID 19 vaccine production and delivery: statements by Pascal CANFIN (Renew, FR) ENVI chair, and Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Session 1- Presentations by Pascal SORIOT, Chief Executive Officer, AstraZeneca, Stéphane BANCEL, Chief Executive Officer, Moderna, Franz-Werner HAAS, Chief Executive Officer, CureVac, accompanied by Antony BLANC, Chief Business Officer, Stan ERCK, President & Chief Executive Officer, Novavax.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Session 1 - CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Exchange of views with CEOs of the pharmaceutical industry on COVID 19 (Corona) vaccine production and delivery. Closing remarks by Thierry BRETON, European Commissioner for Internal Market.

Joint ENVI - ITRE Hearing Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Statement by Thierry BRETON, European Commissioner for Internal Market

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

133 výsledkov